Untitled

Metabolism of Cholesterol and Lipoproteins
Lecture Overview
  • Date: 13.11.2025

  • Instructor: MUDr. Alice Skoumalová, Ph.D.

  • Department: Medical Chemistry and Clinical Biochemistry

Patient Case (Page 2)
  • Patient Description:

    • Age: 45-year-old female

    • Condition: Post acute myocardial infarction (AMI)

Laboratory Tests:

  • Total Cholesterol: 10.92 mmol/l

    • Normal Range: 2.9 - 5.0 mmol/l

Patient History:

  • A significant family history of high cholesterol and acute myocardial infarction (AMI) exists, with two other siblings affected, indicating a possible hereditary component influencing lipid metabolism.

Diagnosis:

  • Familial Hypercholesterolemia:

    • This genetic condition is characterized by severely elevated cholesterol levels in the blood due to mutations in genes responsible for cholesterol metabolism, often leading to premature cardiovascular diseases.

Connection to Acute Myocardial Infarction:

  • Acute myocardial infarction (AMI) is primarily caused by the blockage of a coronary artery, stemmed from atherosclerosis, where high blood cholesterol levels play a pivotal role as risk factors, facilitating plaque formation and subsequent arterial narrowing.

Cholesterol Structure and Characteristics (Page 3)
  • Chemical Structure of Cholesterol:

    • Composed of 27 Carbon atoms featuring a hydroxyl (HO) group, which gives cholesterol its amphipathic nature, allowing it to integrate within cellular membranes.

    • Its structural formula indicates multiple carbon-carbon bonds and functional groups, which are critical for its biological activities.

Role of Cholesterol:

  • Functions:

    • Serves as a structural stabilizer in cell membranes, maintaining fluidity and integrity.

    • Acts as a precursor for various vital biochemical compounds, including bile salts, steroid hormones (such as cortisol and estrogen), and vitamin D (cholecalciferol), instrumental in metabolic regulation and homeostasis.

Sources of Cholesterol (Page 4):

  1. Endogenous Biosynthesis:

    • Approximately 50% of cholesterol is synthesized in the liver, with additional synthesis occurring in the skin and intestine, emphasizing the liver's central role in lipid metabolism.

  2. Exogenous Intake:

    • Cholesterol is absorbed from dietary sources, primarily animal products, contributing to overall cholesterol levels in the body.

Cholesterol in Blood:

  1. Free Form: 1/3

  2. Cholesterol Esters: 2/3

Cholesterol Metabolism (Page 5)

Sources of Cholesterol:

  1. Dietary intake from food sources

  2. De novo synthesis in the liver from acetyl-CoA, illustrating the body's capability to produce cholesterol as required.

Utilization of Cholesterol:

  1. Synthesis of bile acids, essential for fat digestion and absorption.

  2. Acts as a building block for cell membranes, contributing to cell structure and function.

  3. Stored in lipid droplets after esterification with fatty acids, serving as an energy reserve.

  4. Formed into Very Low-Density Lipoprotein (VLDL) to distribute cholesterol to peripheral tissues for use or storage.

Liver’s Role:

  • The liver is crucial for cholesterol homeostasis, orchestrating the uptake, metabolism, and excretion of lipoproteins, specifically High-Density Lipoprotein (HDL), which helps transport cholesterol from tissues back to the liver.

Cholesterol Balance (Page 6)
  • Total Body Cholesterol Content: Approximately 150 g

  • Bile Acids: Ranges between 3-5 g, emphasizing their importance in lipid digestion and absorption.

  • Maintains balance through diverse pathways including biosynthesis, absorption, and excretion.

System Dynamics:

  • Biosynthesis of Cholesterol:

    • Approximately 1 g synthesized per day, alongside an additional 0.5 g from dietary sources (0.2 g specifically from exogenous intake).

    • Key physiological processes include enterohepatic circulation of bile acids, resorption rates exceeding 98-99%, and interactions with gut microbiota that modulate cholesterol metabolism.

Cholesterol Biosynthesis Pathway (Page 7)
  • Location: Occurs within both the cytosol and the Endoplasmic Reticulum (ER) of liver cells.

  • Precursor: Acetyl-CoA, sourced from multiple metabolic pathways:

    1. β-oxidation of fatty acids (derived from the Pentose Phosphate Pathway - PPP).

    2. Oxidation of ketogenic amino acids.

    3. Pyruvate dehydrogenase reaction, involving CoA and ATP for activation.

  • Reducing Agent: NADPH, crucial in various biosynthesis reactions.

Key Steps in Cholesterol Biosynthesis (Page 8-14)
  1. Formation of 3-HMG CoA:

    • This step can occur in both mitochondria (part of the ketone body pathway) and the cytosol, highlighting the centralized metabolism of lipids.

  2. Reduction to Mevalonate:

    • Catalyzed by HMG CoA reductase (the rate-limiting step), taking place in the ER and consuming NADPH.

  3. Regulation of HMG CoA Reductase:

    • Transcriptional Control: Functions similarly to a feedback system, with SREBP (sterol-regulatory element-binding proteins) responding to cholesterol levels, regulating gene expression accordingly.

Regulation Mechanisms:

A. High Cholesterol Level:

  • SREBP remains bound to SCAP (SREBP cleavage-activating protein) within the ER, limiting cholesterol synthesis.

    B. Low Cholesterol Level:

  • SREBP migrates to the Golgi Apparatus (GA), undergoes cleavage, and translocates to the nucleus to enhance gene expression responsible for cholesterol synthesis.

  1. Proteolytic Degradation:

    • Elevated levels of cholesterol and bile acids alter HMG CoA reductase structure, increasing its vulnerability to proteolytic degradation and reducing cholesterol production.

  2. Hormonal Regulation:

    • Glucagon:

      • Stimulates phosphorylation, leading to inhibition of HMG CoA reductase and lowering cholesterol synthesis.

    • Insulin:

      • Promotes dephosphorylation, activating HMG CoA reductase and facilitating cholesterol synthesis.

    • AMP-activated protein kinase:

      • Activated under conditions of low ATP levels, further modulating cholesterol production.

Further Steps in Cholesterol Biosynthesis (Page 12-14):

  1. Phosphorylation: Leading to modification of enzymatic activity and control of cholesterol synthesis rate.

  2. Decarboxylation to Isopentenyl Diphosphate:

    • Requires ATP and serves as a precursor for the synthesis of other isoprenoid compounds (e.g., tocopherol, ubiquinone, carotenoids) essential for various biological functions.

  3. Isomerization: A critical step ensuring proper molecular configuration for subsequent reactions.

  4. Condensation to Geranyl Diphosphate: A key synthetic step in the iscopathways for various sterols.

  5. Formation of Farnesyl Diphosphate:

    • Achieved through the addition of another isopentenyl diphosphate, representing another step towards sterol formation.

  6. Dimerization to Squalene: Essential step in forming cholesterol's precursor.

  7. Cyclization of Squalene:

    • Catalyzed by oxygen and cytochrome P450 monooxygenase enzymes, marking the transition from linear to cyclic structures.

  8. Formation of Cholesterol:

    • Involves the cleavage of three methyl groups and structural rearrangements, ultimately producing cholesterol.

Treatment Options for High Cholesterol (Page 15)
  • Patient Case Recap:

    • Diagnosis: Familial hypercholesterolemia

    • Laboratory tests confirm significantly elevated cholesterol levels necessitating intervention.

Suggested Treatments:

  1. HMG-CoA Reductase Inhibition:

    • Statins are the primary class of medications used to lower cholesterol by blocking the enzyme responsible for its synthesis.

  2. Cholesterol Absorption Inhibition:

    • Medications such as Ezetimibe can be prescribed to reduce cholesterol absorption in the intestine, complementing statin therapy.

  3. Other Mechanisms:

    • Conversion of cholesterol to bile acids should be promoted; interventions targeting this pathway can significantly impact hyperlipidemia management and cardiovascular disease prevention.